ADH-2

· Calcilytix Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADH-2, covering 2025-04-04 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: ADH1 and ADH2 Disease Monitoring Study (DMS)